ELBA: Exemestane and Lapatinib in Advanced Breast Cancer (ELBA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01005641
Recruitment Status : Withdrawn (Study not started for administrative reasons)
First Posted : November 2, 2009
Last Update Posted : July 13, 2012
Information provided by:
National Cancer Institute, Naples

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : October 2011
  Estimated Study Completion Date : March 2012